Keywords: ucb, threatened, claritin, otc, version, usa-based, schering-plough

UCB not threatened by Claritin's OTC version

Article | 18 March 2002

Print This

As USA-based Schering-Plough has decided to sell an OTC version of itsanti-allergy drug Claritin (loratadine) in the USA, Belgium-based UCB ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in